SHAREHOLDER ALERT: The M&A Class Action Firm Announces An Investigation of Penumbra, Inc. (NYSE: PEN)

Core Viewpoint - Monteverde & Associates PC is investigating the proposed sale of Penumbra, Inc. to Boston Scientific Corporation, questioning the fairness of the deal for Penumbra shareholders [1]. Company Overview - Monteverde & Associates PC is recognized as a Top 50 Firm in the 2024 ISS Securities Class Action Services Report and has recovered millions for shareholders [1]. - The firm is located in the Empire State Building, New York City, and specializes in class action securities litigation [2]. Transaction Details - Under the proposed transaction, Penumbra shareholders are expected to receive either 3.8721 shares of Boston Scientific common stock or $374.00 in cash for each share of Penumbra common stock [1].